Drug intelligence / Profile preview

alginate oligosaccharide

Development stage
Phase 2
Lead developer
Algipharma
Modality
Microbiome-Derived Products → Microbiome Therapeutics
Administration
Inhalation, Oral
01

Overview

Alginate oligosaccharide (AOS) is a collective term for low-molecular-weight polymers derived from the degradation of alginate, a polysaccharide extracted from brown seaweed. [5, 13] These oligosaccharides are composed of β-D-mannuronic acid (M) and α-L-guluronic acid (G) monomers. [5] AOS is considered a nutraceutical or dietary supplement and has been approved as a new food raw material in China. [16] It demonstrates a wide array of biological activities, including prebiotic, anti-inflammatory, antioxidant, immunomodulatory, and antimicrobial effects. [2, 8, 9] The mechanism of action is multifaceted; AOS functions as a prebiotic to beneficially modulate gut microbiota, which in turn can influence systemic health. [7, 9, 14] Its anti-inflammatory properties are partly mediated through the inhibition of the Toll-like receptor 4 (TLR4)/NF-κB signaling pathway, reducing the production of inflammatory mediators. [2, 9, 23] AOS also exerts antioxidant effects by activating the Nrf2 pathway. [12, 17] A specific G-block fragment of AOS, known as OligoG, is being developed by AlgiPharma as a pharmaceutical for cystic fibrosis, where it works by disrupting bacterial biofilms. [4, 9] Other research, including a clinical trial at Shenzhen University General Hospital, is investigating the use of AOS tablets to improve semen quality in men with oligozoospermia, with preclinical studies suggesting it works by improving the testicular microenvironment and gut health. [5, 11, 14]

Other names
褐藻寡糖Alginate oligosaccharidesAlginate-derived oligosaccharideAOS tablets褐藻寡糖片

Beyond the preview

Go deeper on alginate oligosaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alginate oligosaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call